INTS
INTENSITY THERAPEUTICS, INC.
Key Financials
Operating Income
$-11972000
↑ 27.8%
Net Income
$-11606000
↑ 28.7%
Shareholders' Equity
$11.9M
↑ 307.0%
Total Liabilities
$2.2M
↑ 19.3%
Total Assets
$14.1M
↑ 194.8%
Cash & Equivalents
$11.9M
↑ 360.3%
EPS (Diluted)
$-8.56
↓ 631.6%
Operating Cash Flow
$-9233000.00
↑ 39.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEFA14A | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 4 | 3/30/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
| 10-K | 3/27/2026 | View on SEC |
| 8-K | 3/23/2026 | View on SEC |
| 424B5 | 3/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INTS |
| Company Name | INTENSITY THERAPEUTICS, INC. |
| CIK | 1567264 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 203-221-7381 |